Ranbaxy Laboratories is in speaks with Ind-Swift Labs

Indian medicine manufacturer Ranbaxy Laboratories is in speaks with Ind-Swift Labs to source ingredient to produce a generic version of Pfizer Inc.’s (PFE) Lipitor blood cholesterol medicine.

Ind-Swift vice chairman N. R. Munjal stated that the firm is talking about various choices to deliver intermediate or final active pharmaceutical raw materials atorvastatin to Ranbaxy.

Ranbaxy plans to release the cholesterol medicine in the United states. at the end of November, but regulatory and producing issues at the Indian firm have late FDA authorization for the medicine.

Be Sociable, Share!
Tags: ,

Stock Market Basics For Beginners

Why does Securities Market require Regulators?

Why does Securities Market require Regulators? The lack of conditions of best competitors in the securities market creates the position of the Regulator very important. The regulator makes sure that the ...…

Term Debt Instrument

Term Debt Instrument Debt instrument shows an agreement by which one party gives cash to another on pre-determined conditions with regards to rate as well as periodicity of ...…

After Tax

After Tax After Tax When you are investing in loan tools such as bonds, debentures or fixed deposits, and when you are an incom_tax payer, it's ...…

What IS a Share?

What IS a Share? [ad name="468x15- 5 link"] share is a unit of account for various financial instruments including mutual funds, stocks, limited partnerships, and REIT's. In simple Words, stock ...…

Active Stock

Active Stock Share in which there are actually regular and day-to-day dealings, as distinguished from partly effective stocks in which dealings (buy-sell) aren't so frequent. Most 'shares or ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics